Who is sponsoring NCT05399979?

NCT05399979 is sponsored by Augusta University.

What drugs are being tested in NCT05399979?

Interventions in NCT05399979: Labor Neuraxial Analgesia.

What condition does NCT05399979 study?

NCT05399979 studies Fetal Bradycardia.

Is NCT05399979 still recruiting?

NCT05399979 is currently completed. Last updated 3 June 2022.

Last reviewed 2022-06-03 · How we verify

NCT05399979

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fetal Heart Rate Changes and Labor Neuraxial Analgesia: a Machine Learning Approach

Completed Last updated 3 June 2022

What this trial tests

trial testing Labor Neuraxial Analgesia in Fetal Bradycardia in 1,077 participants. Completed in 5 May 2022.

Timeline

9 June 2021

Primary endpoint
5 May 2022

5 May 2022

Quick facts

Lead sponsor	Augusta University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,077
Start date	9 June 2021
Primary completion	5 May 2022
Estimated completion	5 May 2022
Sites	1 location across United States

Drugs / interventions tested

Labor Neuraxial Analgesia

Conditions studied

Fetal Bradycardia — all drugs for Fetal Bradycardia →

Sponsor

Augusta University

Who can join

18 and older, female only, with Fetal Bradycardia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to perform statistical inference and prediction of changes in fetal heart rate during active labor in healthy pregnant women by comparing three different machine learning methods

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fetal heart rate changes and labor neuraxial analgesia: a machine learning approach.
Riveros-Perez E, Polania-Gutierrez JJ, Avella-Molano B. · · 2023 · cited 3× · PMID 37211590 · DOI 10.1186/s12884-023-05632-3

Verify or expand the search:

Other Augusta University trials

Trials by the same sponsor.

NCT07341841 — Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral Study · NA · enrolling by invitation
NCT07489144 — CO-creating Novel, Feasible, and Inclusive Research Methods · NA · active not recruiting
NCT06514014 — Transition From Donor Milk: a Feasibility Study · NA · recruiting
NCT06907992 — A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated C · not yet recruiting
NCT06058169 — Effects of Home Base Whole-body Vibration in Osteoarthritis. (VIBE-Rx2) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05399979 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Augusta University
Last refreshed: 3 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05399979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing